XML 53 R33.htm IDEA: XBRL DOCUMENT v3.6.0.2
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2016
Disclosure Shareholders Equity [Abstract]  
Schedule of share repurchases
The Company has made the following share repurchases (in thousands):
 
 
For the Years Ended December 31,
 
 
2016
 
2015
 
2014
Total number of shares repurchased and retired
 
2,908

 
2,179

 
554

Total investment
 
$
245,816

 
$
293,616

 
$
81,812

Schedule of cash dividends declared per common share
Dividends. Quarterly and total year cash dividends declared per common share for the year ended December 31, 2016 and 2015 were as follows: 
 
 
For the Years Ended December 31,
 
 
2016
 
2015
Quarterly dividend declared and paid per common share
 
$
0.55

 
$
0.53

Total dividends declared and paid per common share
 
$
2.20

 
$
2.12

Schedule of reconciliation of weighted average number of shares
A reconciliation of these amounts is as follows (in thousands):
 
For the Years Ended December 31,
 
2016
 
2015
 
2014
Weighted average number of common shares outstanding
64,033
 
65,719
 
65,904

Director Plan and deferred stock units
162
 
210
 
196

ESOP
101
 
91
 
75

Common shares outstanding—basic
64,296
 
66,020
 
66,175

Dilutive effect of restricted stock awards
150
 
255
 
359

Dilutive effect of stock option awards
712
 
1,209
 
1,695

Common and potential common shares outstanding—diluted
65,158
 
67,484
 
68,229

Schedule of changes in accumulated other comprehensive income (loss) balances
Changes in the accumulated other comprehensive loss balance is as follows (in thousands):
 
Foreign
Currency
Items
 
Cash Flow
Hedging Derivatives
 
Accumulated Other
Comprehensive
Loss
Balance as of December 31, 2015
$
(64,360
)
 
$
1,868

 
$
(62,492
)
Reclassification to the income statement

 
4,643

 
4,643

Change in fair value
(19,773
)
 
(6,215
)
 
(25,988
)
Balance as of December 31, 2016
$
(84,133
)
 
$
296

 
$
(83,837
)
Schedule of gains and losses, net of tax, reclassified from accumulated other comprehensive income into the income statement for cash flow derivatives designated as hedging instruments
The table below provides data about the amount of gains and losses, net of tax, reclassified from accumulated other comprehensive loss into the income statement for cash flow derivatives designated as hedging instruments for the year ended December 31, 2016 and 2015 (in thousands): 
Derivatives in Cash
Flow Hedging Relationships
Location of Gain (Loss)
Reclassified from
Accumulated OCI
into Income
 
For the Years Ended December 31,
 
2016
 
2015
Foreign currency contracts
Other expense, net
 
$
1,325

 
$
(8,399
)
Foreign currency contracts
Cost of sales
 
3,318

 
4,549

Total
 
 
$
4,643

 
$
(3,850
)